T1	Participants 70 93	moderate to severe COPD
T2	Participants 201 205	COPD
T3	Participants 383 418	symptomatic moderate to severe COPD
T4	Participants 519 701	40 years or older with cigarette smoking history ≥10 pack-years and with the diagnosis of COPD and post-bronchodilator FEV(1) ≥40 to ≤ 80% of predicted normal and FEV(1)/FVC of ≤0.70
T5	Participants 1599 1634	subjects with COPD treated with TIO
